Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1639 1681 1682 1684 1799
This examiner grants 62% of resolved cases
Elizabeth Rose Lafave works in Tech Center 1700 and Art Unit 1639. The examiner has resolved 56 cases. The data shows an allowance rate of 62.5 percent, which is relatively high. An interview lift of 45.4 percent indicates that interviews are a highly effective tool for increasing the likelihood of a grant. This 45.4 percent lift suggests that direct engagement can significantly overcome prosecution hurdles.
The median days to allowance is 1553, indicating a relatively long process from filing to grant. With 56 resolved cases, the examiner's data is robust and reliable. The 62.5 percent allowance rate and 1553 median days to allowance set the stage for prosecution. Practitioners should prioritize interviews given the 45.4 percent lift observed across these 56 cases.
In Art Unit 1639, the 45.4 percent interview lift is a key tactical advantage for applicants. The 62.5 percent allowance rate suggests a consistent examination style. The 1553 median days to allowance is an important factor for managing client expectations regarding timing. By leveraging the 45.4 percent lift, practitioners can improve their outcomes beyond the baseline 62.5 percent allowance rate.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17801517 | METHODS OF SPATIALLY RESOLVED SINGLE CELL SEQUENCING | Non-Final OA | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA |
| 17582820 | CRISPR/CAS TRANSCRIPTIONAL MODULATION | Final Rejection | The Regents of the University of California |
| 17604881 | BIOPOLYMER ANALYSIS DEVICE, BIOPOLYMER ANALYSIS EQUIPMENT, AND BIOPOLYMER ANALYSIS METHOD | Non-Final OA | HITACHI HIGH-TECH CORPORATION |
| 17788003 | METHODS AND ARRAYS FOR IDENTIFYING THE CELL OR TISSUE ORIGIN OF DNA | Final Rejection | Ramot at Tel-Aviv University Ltd. |
| 18607277 | MULTIGENE ANALYSIS OF TUMOR SAMPLES | Non-Final OA | Foundation Medicine, Inc. |
| 17538812 | SYSTEM AND METHOD FOR DETECTION OF GENETIC ALTERATIONS | Non-Final OA | Illumina, Inc. |
| 18009377 | A Method for Assessing Transduction Efficiency and/or Specificity of Vectors at Single Cell Level | Final Rejection | AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH |
| 17787898 | METHOD FOR IDENTIFYING REGULATORY ELEMENTS | Non-Final OA | ASKBIO INC. |
| 18041902 | EUKARYOTIC DNA REPLICATION ORIGINS, AND VECTOR CONTAINING THE SAME | Non-Final OA | UNIVERSITÉ DE MONTPELLIER |
| 17721680 | BARCODE-BASED NUCLEIC ACID SEQUENCE ASSEMBLY | Final Rejection | Twist Bioscience Corporation |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy